AbbVie Inc. (ABBV) Presents at Wells Fargo 21st Annual Healthcare Conference TranscriptSeeking Alpha • 09/09/26
AbbVie Highlights SKYRIZI, RINVOQ Growth and Pipeline Catalysts at Wells Fargo ConferenceMarketBeat • 09/09/26
AbbVie (ABBV) Registers a Bigger Fall Than the Market: Important Facts to NoteZacks Investment Research • 09/08/26
Plastic surgery is booming with boomers. Here's how to cash in on the antiaging craze.Market Watch • 09/05/26
AbbVie: Shares Defy Sell-Side Downgrades, And That's Bullish (Technical Analysis)Seeking Alpha • 09/04/26
AbbVie Announces Positive Topline Results from the Phase 3 CERVINO Trial Showing Etentamig Significantly Improved Response Rate and Progression-Free Survival in Patients with Relapsed/Refractory Multiple MyelomaPRNewsWire • 09/03/26
AbbVie to Present at the Morgan Stanley 24th Annual Global Healthcare ConferencePRNewsWire • 09/03/26
SkinMedica® Adds Barrier Calming Cream to its Collection of Regenerative Skincare OfferingsPRNewsWire • 09/01/26
FDA Nods Lilly-Roche's Alzheimer's Blood Test: Healthcare ETFs to Track NowZacks Investment Research • 08/27/26
When Inflation Is Sticky, 5 Dividend Aristocrats Are the Stocks to Own Now and Forever24/7 Wall Street • 08/27/26
AbbVie Submits Regulatory Application to EMA for SKYRIZI® (risankizumab) Subcutaneous Induction for Adults with Moderately to Severely Active Crohn's DiseasePRNewsWire • 08/27/26